Alcon Laboratories (UK) Ltd withdraws its application to extend the marketing authorisation for Opatanol

The European Medicines Agency has been formally notified by Alcon Laboratories (UK) Ltd of its decision to withdraw its application for an extension of the marketing authorisation for the medicinal product Opatanol (Olopatadine hydrochloride). ... Read more